Analysis Apollo Medical Holdings Inc (AMEH)
5/28/2024
Analysis of Apollo Medical Holdings Inc (AMEH)
Apollo Medical Holdings Inc (AMEH) has shown a consistent upward trend in its stock price over the past few days. The Relative Strength Index (RSI) values have been increasing, indicating a strengthening bullish momentum. The Moving Average Convergence Divergence (MACD) indicator has also been positive, with the MACD line consistently above the signal line.The stock has been trading above its Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA), suggesting a bullish sentiment in the market. The MACD histogram has been showing positive values, indicating a potential continuation of the upward trend.
Overall, based on the technical indicators, Apollo Medical Holdings Inc appears to be in a strong bullish phase, with potential for further price appreciation. However, it is essential to consider other factors such as market conditions, news, and fundamental analysis before making any investment decisions.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided yet. The previous results from February 27, 2025, were related to the Transfer Agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not provided at a specific time. The results from August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits for a specific company.In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31% and the company's fiscal year ends on September 30, 2023. The income statement reveals an EBITDA of $131.39 billion, revenue of $381.62 billion, and a diluted EPS of 6.44.
Moving on to stock statistics, the company has a short ratio of 1.66, with 94.31 million shares shorted out of 15.31 billion float shares. The average 10-day volume is 52.90 million shares, while the average 90-day volume is 62.82 million shares. The stock has a market capitalization of $2.91 trillion.
Valuation metrics show a PEG ratio of 26.21, forward PE of 26.21, trailing PE of 29.43, and a price to book ratio of 39.18. The enterprise value is $2.95 trillion, with a price to sales ratio of 7.62 and enterprise to EBITDA ratio of 22.75.
The stock price summary includes a beta of 1.26, 50-day moving average of $173.69, 200-day moving average of $180.79, and a 52-week range from $164.08 to $199.62.
Lastly, in dividends and splits, the company has a payout ratio of 14.93% and a forward annual dividend yield of 0.53%. The dividend date is May 16, 2024, with an ex-dividend date of May 10, 2024. The last split date was on August 31, 2020, with a 4-for-1 split. The trailing annual dividend rate is $0.97 with a yield of 0.51%, while the 5-year average dividend yield is 0.73%.
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating that the company is facing higher production or acquisition costs.
3. The gross profit margin has remained relatively stable over the years, indicating that the company has been able to maintain its profitability despite the increase in costs.
4. The operating income has also shown a consistent growth trend, reaching $114.3 billion in 2023.
5. The net income has been increasing over the years, from $57.4 billion in 2020 to $97 billion in 2023, showing that the company is effectively managing its expenses and taxes.
6. The earnings per share (EPS) have also been increasing, indicating that the company's profitability is improving on a per-share basis.
7. The company has been able to generate positive EBITDA and EBIT figures consistently, showing its operational efficiency and profitability.
8. Overall, the financial performance of the company in terms of revenues has been positive, with steady growth in sales and profitability metrics.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has been relatively stable over the years, indicating consistent operational performance.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company's cash flow statement reflects a mix of operational, financing, and investing activities that have contributed to its financial position over the years.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and years, with the numbers generally increasing compared to the previous year's earnings. This indicates potential growth and improvement in the company's financial performance according to analysts' projections.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with a slightly higher growth rate expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions about the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average growth rate for the past 5 years is 20.1% per annum.
6. Next 5 Years (per annum): The estimated growth rate for the next 5 years is 11% per annum.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the near term compared to the past performance. However, the company is still projected to maintain a double-digit growth rate over the next 5 years according to analyst consensus.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the majority clustering around the median and average values. The current price is below both the median and average forecast, suggesting that there may be potential for the security to increase in value according to the analysts' predictions.
MACD of AMEH
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
